Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Hepatitis E virus infection in a liver transplant recipient in the United States: a case report.

Te HS, Drobeniuc J, Kamili S, Dong C, Hart J, Sharapov UM.

Transplant Proc. 2013 Mar;45(2):810-3. doi: 10.1016/j.transproceed.2012.08.020.

PMID:
23498824
2.

Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.

Klein F, Neuhaus R, Hofmann J, Rudolph B, Neuhaus P, Bahra M.

Exp Clin Transplant. 2015 Jun;13(3):283-6. doi: 10.6002/ect.2013.0286. Epub 2014 Apr 28.

3.

Chronic hepatitis E infection in children with liver transplantation.

Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, Houde A, Alvarez F.

Gut. 2012 Apr;61(4):597-603. doi: 10.1136/gutjnl-2011-300708. Epub 2011 Nov 23.

PMID:
22115826
4.

Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk.

Lee GH, Tan BH, Teo EC, Lim SG, Dan YY, Wee A, Aw PP, Zhu Y, Hibberd ML, Tan CK, Purdy MA, Teo CG.

Gastroenterology. 2016 Feb;150(2):355-7.e3. doi: 10.1053/j.gastro.2015.10.048. Epub 2015 Nov 6.

PMID:
26551551
5.

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation.

Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssière L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L.

Transplantation. 2010 Feb 15;89(3):353-60. doi: 10.1097/TP.0b013e3181c4096c.

PMID:
20145528
6.

Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States.

Sue PK, Pisanic N, Heaney CD, Mixson-Hayden T, Kamili S, Nelson K, Schwarz KB, Forman M, Valsamakis A, Ticehurst J, Karnsakul W.

Transpl Infect Dis. 2015 Apr;17(2):284-8. doi: 10.1111/tid.12366.

7.

Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.

Pischke S, Greer M, Hardtke S, Bremer B, Gisa A, Lehmann P, Haverich A, Welte T, Manns MP, Wedemeyer H, Gottlieb J; Hepatitis E study group..

Transpl Infect Dis. 2014 Apr;16(2):333-9. doi: 10.1111/tid.12183. Epub 2014 Jan 20.

PMID:
24438577
8.

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.

Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J, Strassburg CP, Lehner F, Raupach R, Bremer B, Magerstedt P, Cornberg M, Seehusen F, Baumgaertner W, Klempnauer J, Izopet J, Manns MP, Grummer B, Wedemeyer H.

Liver Transpl. 2010 Jan;16(1):74-82. doi: 10.1002/lt.21958.

9.

Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India.

Munjal S, Gupta N, Sharma RK, Gupta A, Prasad N, Kaul A, Bhadauria D, Goel A, Aggarwal R.

Indian J Gastroenterol. 2014 Nov;33(6):550-3. doi: 10.1007/s12664-014-0508-5. Epub 2014 Oct 1.

PMID:
25266354
10.

Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.

Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N.

Liver Int. 2016 Mar;36(3):328-33. doi: 10.1111/liv.12911. Epub 2015 Dec 30.

PMID:
26179015
11.

Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting.

Galante A, Pischke S, Polywka S, Luetgehethmann M, Suneetha PV, Gisa A, Hiller J, Dienes HP, Nashan B, Lohse AW, Sterneck M.

Transpl Infect Dis. 2015 Aug;17(4):617-22. doi: 10.1111/tid.12411. Epub 2015 Jul 14.

PMID:
26094550
12.

Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity.

Nijskens CM, Pas SD, Cornelissen J, Caliskan K, Hoek RA, Hesselink DA, van der Eijk AA, de Man RA.

J Clin Virol. 2016 Jan;74:82-7. doi: 10.1016/j.jcv.2015.11.038. Epub 2015 Dec 2.

PMID:
26687439
13.

Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.

Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A.

J Heart Lung Transplant. 2011 Jul;30(7):841-3. doi: 10.1016/j.healun.2011.03.013. Epub 2011 Apr 22.

PMID:
21515077
14.

First human case of co-infection with two different subtypes of hepatitis E virus.

Moal V, Gerolami R, Colson P.

Intervirology. 2012;55(6):484-7. doi: 10.1159/000335664. Epub 2012 Mar 6.

PMID:
22398950
15.

Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area.

Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R.

J Viral Hepat. 2013 Apr;20(4):e138-40. doi: 10.1111/jvh.12027. Epub 2012 Nov 26.

PMID:
23490383
16.

Infection with hepatitis E virus in kidney transplant recipients in southeastern France.

Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gérolami R, Berland Y, Colson P.

J Med Virol. 2013 Mar;85(3):462-71. doi: 10.1002/jmv.23469. Epub 2012 Dec 12.

PMID:
23239466
17.

First report and molecular characterization of hepatitis E virus infection in renal transplant recipients in Brazil.

Passos AM, Heringer TP, Medina-Pestana JO, Ferraz ML, Granato CF.

J Med Virol. 2013 Apr;85(4):615-9. doi: 10.1002/jmv.23494. Epub 2013 Feb 4.

PMID:
23382036
18.

Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.

Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, Berg T, Hofmann J.

J Hepatol. 2012 Feb;56(2):500-2. doi: 10.1016/j.jhep.2011.06.021. Epub 2011 Jul 26.

19.

Acute Hepatitis E Virus infection with coincident reactivation of Epstein-Barr virus infection in an immunosuppressed patient with rheumatoid arthritis: a case report.

Schultze D, Mani B, Dollenmaier G, Sahli R, Zbinden A, Krayenbühl PA.

BMC Infect Dis. 2015 Oct 29;15:474. doi: 10.1186/s12879-015-1146-y.

20.

Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.

Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, Rapp G, Schöbel A, Lohse AW, Polywka S, Pischke S, Herker E, Dandri M, Lütgehetmann M.

J Hepatol. 2016 May;64(5):1033-40. doi: 10.1016/j.jhep.2016.01.011. Epub 2016 Jan 22.

PMID:
26805671

Supplemental Content

Support Center